Portal de Periódicos da CAPES

The utility of the Edmonton Obesity Staging System for the prediction of COVID-19 outcomes: a multi-centre study

2022; Springer Nature; Volume: 46; Issue: 3 Linguagem: Inglês

10.1038/s41366-021-01017-8

1476-5497

Marcela Rodríguez-Flores, Eduardo W. Goicochea-Turcott, Leonardo Mancillas‐Adame, Nayely Garibay-Nieto, Malaquías López‐Cervantes, Mario E. Rojas-Russell, Lilia Castro-Porras, Eduardo Gutiérrez-León, Luis Fernando Campos-Calderón, Karen Pedraza-Escudero, Karina Aguilar-Cuarto, Eréndira Villanueva-Ortega, Joselín Hernández-Ruiz, Guadalupe Guerrero‐Avendaño, Sheyla M. Monzalvo-Reyes, Rafael García-Rascón, Israel N. Gil-Velázquez, Dora E. Cortés-Hernández, Marcela Granados-Shiroma, Brenda G. Alvarez-Rodríguez, Martha Leticia Cabello Garza, Zaira L. González-Contreras, Esteban Picazo-Palencia, Juana M. Cerda-Arteaga, Héctor Raúl Pérez-Gómez, R Calva-Rodríguez, Gerardo Sánchez-Rodríguez, Leslie D. Carpio-Vázquez, María A. Dávalos-Herrera, Karla M. Villatoro-de-Pleitez, Melissa D. Suárez-López, María G. Nevárez-Carrillo, Karina Pérez-Alcántara, Roopa Mehta, Edurne Sandoval Diez, Edward W. Gregg,

Pancreatitis Pathology and Treatment

Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of the Edmonton Obesity Staging System (EOSS), a clinical classification tool that assesses obesity-related comorbidity, is compared with BMI, with respect to adverse COVID-19 outcomes.